Anhui Huaheng Biotechnology Co., Ltd. (688639.SH) issues a profit warning, expecting a net profit of 180 million to 220 million yuan in 2024, a year-on-year decrease of 51.01% to 59.92%.
Huaheng Biotechnology (688639.SH) issued an announcement, expecting to achieve a net profit attributable to the owners of the parent company in 2024...
Anhui Huaheng Biotechnology Co., Ltd. (688639.SH) announced that it is expected to achieve a net profit attributable to the owners of the parent company of 180 million to 220 million yuan in 2024, a decrease of 229.06 million to 269.06 million yuan compared to the same period last year, representing a year-on-year decrease of 51.01% to 59.92%. It is expected to achieve a net profit attributable to the owners of the parent company, excluding non-recurring gains and losses, of 170 million to 210 million yuan in 2024, a decrease of 228.09 million to 268.09 million yuan compared to the same period last year, representing a year-on-year decrease of 52.07% to 61.20%.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


